The deep brain stimulation response network in Parkinson’s disease operates in the high beta band
Deep brain stimulation (DBS) of the subthalamic nucleus improves motor symptoms in patients with Parkinson's disease. Using functional MRI, optimal DBS response networks have been characterized. However, neural activity associated with Parkinsonian symptoms is magnitudes faster than what can be resolved by this method. Although both spatial and temporal domains of these networks appear crucial, no single study has yet investigated both domains simultaneously. Here, we aimed at closing this gap by analysing electrophysiological data from a total of n = 127 hemispheres. Using subthalamic local field potentials that were recorded concurrently alongside whole-brain magnetoencephalography in a multi-centre cohort of patients who underwent subthalamic DBS for the treatment of Parkinson's disease (n = 100 hemispheres), we analysed the DBS response network in both spatial and temporal domains. In every cortical vertex, cortico-subthalamic coupling was correlated with stimulation outcomes. This network spatially resembled functional MRI-based findings (R = 0.40, P = 0.039) and explained significant amounts of variance in clinical outcomes (βstd = 0.30, P = 0.002), whereas theta-alpha and low beta coupling did not show significant associations with DBS response (theta-alpha: βstd = -0.02, P = 0.805; low beta: βstd = -0.08, P = 0.426). The 'optimal' high beta coupling map was robust when subjected to various cross-validation designs (10-fold cross-validation: R = 0.29, P = 0.009; split-half design: R = 0.31, P = 0.026) and was able to predict outcomes across DBS centres [R = 0.74; P(1) = 8.9 × 10-5]. We identified a DBS response network that resembles the previously defined MRI network and operates in the high beta band. Maximal connectivity to this network was associated with optimal DBS outcomes and was able to cross-predict clinical improvements across DBS surgeons and centres.
Authors
- Andrea A. Kühn (ORCID: https://orcid.org/0000-0002-4134-9060)
- Alexandra Steina (ORCID: https://orcid.org/0009-0005-6361-8101)
- Bahne H. Bahners (ORCID: https://orcid.org/0000-0003-1963-9798)
- Konstantin Butenko (ORCID: https://orcid.org/0000-0002-4509-4624)
- Michael D. Fox (ORCID: https://orcid.org/0000-0002-5004-1025)
- Roxanne Lofredi (ORCID: https://orcid.org/0000-0002-1845-8250)
- Nanditha Rajamani (ORCID: https://orcid.org/0000-0002-2511-9839)
- Jan Vesper
- Esther Florin (ORCID: https://orcid.org/0000-0001-8276-2508)
- Wolf‐Julian Neumann (ORCID: https://orcid.org/0000-0002-6758-9708)
- Kai Miller
- J. Hirschmann
- Markus Pd Dr. med. Butz
- Barbara Hollunder (ORCID: https://orcid.org/0000-0003-0104-6927)
- Garance M. Meyer (ORCID: https://orcid.org/0000-0002-3350-6070)
- Lukas L. Goede (ORCID: https://orcid.org/0000-0001-6026-185X)
- Frédéric Schaper (ORCID: https://orcid.org/0000-0001-5487-0923)
- Matthias Sure (ORCID: https://orcid.org/0000-0001-7448-5563)
- Patricia Zvarova (ORCID: https://orcid.org/0009-0004-7831-8796)
- Lauren A. Hart
- Fayed Rassoulou
- Julianna Pijar (ORCID: https://orcid.org/0000-0001-5777-9017)
- Savir Madan
- Tilmann H. Sander
- K. Faust
- Clemens Neudorfer
- Alfons Schnitzler
- Christian J Hartmann
- Andreas Horn
Institutions
- Physikalisch-Technische Bundesanstalt (DE)
- Mayo Clinic (US)
- German Center for Neurodegenerative Diseases (DE)
- Humboldt-Universität zu Berlin (DE)
- Massachusetts General Hospital (US)
- Düsseldorf University Hospital (DE)
- Circuit Therapeutics (United States) (US)
- Mayo Clinic in Arizona (US)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Mayo Clinic in Florida (US)
- University Hospital Cologne (DE)
- Heinrich Heine University Düsseldorf (DE)
Publication Details
- Journal
- Brain
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1093/brain/awaf445
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00